Hardell includes a lot of information about conflicts of interest in many of the most influential groups, such as WHO, ICNIRP and IEEE.
“As a general rule, scientists who are of the opposing opinion, i.e., that there are health risks associated with exposure to RF radiation, have never been invited to take part of these expert groups. Thus, the opinions expressed in these reports are not representative of the opinions in the scientific community on effects from EMFs.”
Health Council of the Netherlands and evaluation of the fifth generation, 5G, for wireless communication and cancer risks
“The current evaluation by the Health Council of the Netherlands is based on a WHO draft and SSM report. It also recommends using ICNIRP guidelines, considered to be insufficient to protect against health hazards, such as cancer, by the majority of the scientists in this field (https://www.emfscientist.org). The report does not represent a thorough, balanced, objective, and up-to-date evaluation of cancer risks and other hazardous effects from RF radiation. It is also strikingly contradictory as it concludes that serious health effects such as cancer and birth defects are ‘possible.’ Yet it has no objection to the roll-out of 5G and recommends that later studies are performed to study health outcomes such as cancer and birth defects. Thus, no lessons are learned from existing observations on increased cancer risks.
The conclusion by the Commission that there is no reason to stop the use of lower frequencies for 5G up to 3.5 GHz because of no “proven adverse health effects,” merely reflects the biased conclusions by ICNIRP dominated groups. Thus that conclusion must be dismissed, and new guidelines for previous and new frequencies must be established considering the new technology, the different propagation pattern for 5G, and increased RF radiation.
A moratorium is urgently required on the implementation of 5G for wireless communication. Ultimately, wired solutions are preferred.”
Hardell L. Health Council of the Netherlands and evaluation of the fifth generation, 5G, for wireless communication and cancer risks. World J Clin Oncol 2021; 12(6): 393-403 [PMID: 34189065 DOI: 10.5306/wjco.v12.i6.393]